AyuVis Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

AyuVis General Information

Description

Developer of biopharmaceutical drugs designed to prevent inflammatory and infectious diseases. The company offers novel multifunctional molecules that suppress hyperinflammation, minimize tissue damage, and restore the desired therapeutic immune response, enabling medical researchers to improve treatment prospects for patients with intra-abdominal infections and sepsis.

Contact Information

Website
www.ayuvis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3500 Camp Bowie Boulevard
  • EAD-116J
  • Fort Worth, TX 76107
  • United States
+1 (817)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3500 Camp Bowie Boulevard
  • EAD-116J
  • Fort Worth, TX 76107
  • United States
+1 (817)

AyuVis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AyuVis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 08-Sep-2023 Completed Clinical Trials - Phase 1
8. Grant 17-May-2023 Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 09-Aug-2022 Completed Clinical Trials - Phase 1
6. Grant 12-May-2022 Completed Clinical Trials - Phase 1
5. Seed Round 01-Feb-2022 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator Completed Clinical Trials - Phase 1
3. Grant 01-Sep-2017 Completed Clinical Trials - Phase 1
2. Grant 09-Jan-2017 $274K Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 28-Apr-2016 Completed Clinical Trials - Phase 1
To view AyuVis’s complete valuation and funding history, request access »

AyuVis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical drugs designed to prevent inflammatory and infectious diseases. The company offers novel
Drug Discovery
Fort Worth, TX
10 As of 2026

Union, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AyuVis Competitors (1)

One of AyuVis’s competitors is Prokaryotics, a Corporation company based in Union, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prokaryotics Corporation Union, NJ
You’re viewing 1 of 1 competitors. Get the full list »

AyuVis Patents

AyuVis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250332183-A1 Compositions and methods for the stimulation of intermediate macrophages and treatments therewith Pending 30-Apr-2024
WO-2025231092-A1 Compositions and methods for the stimulation of intermediate macrophages and treatments therewith Pending 30-Apr-2024
AU-2023276287-A1 Novel immunodulating small molecules Pending 25-May-2022
EP-4531867-A1 Novel immunodulating small molecules Pending 25-May-2022
EP-4531867-A4 Novel immunodulating small molecules Pending 25-May-2022 A61K31/7034
To view AyuVis’s complete patent history, request access »

AyuVis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AyuVis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ignite Healthcare Network Accelerator/Incubator
National Heart, Lung, and Blood Institute Government
MassChallenge Accelerator/Incubator
Eunice Kennedy Shriver National Institute of Child Health and Human Development Government
HSC Next Accelerator/Incubator
To view AyuVis’s complete investors history, request access »

AyuVis FAQs

  • When was AyuVis founded?

    AyuVis was founded in 2014.

  • Where is AyuVis headquartered?

    AyuVis is headquartered in Fort Worth, TX.

  • What is the size of AyuVis?

    AyuVis has 10 total employees.

  • What industry is AyuVis in?

    AyuVis’s primary industry is Drug Discovery.

  • Is AyuVis a private or public company?

    AyuVis is a Private company.

  • What is AyuVis’s current revenue?

    The current revenue for AyuVis is .

  • How much funding has AyuVis raised over time?

    AyuVis has raised $2.43M.

  • Who are AyuVis’s investors?

    Ignite Healthcare Network, National Heart, Lung, and Blood Institute, MassChallenge, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and HSC Next have invested in AyuVis.

  • Who are AyuVis’s competitors?

    Prokaryotics is a competitor of AyuVis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process